Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast CancerMelinda L. Telli, Andrea L. Richardson, Jerry S. Lanchbury et al.|Clinical Cancer Research|2016Cited by 1.2k
Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell CharacteristicsBryan T. Hennessy, Gordon B. Mills|Cancer Research|2009Cited by 857
Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancerChad J. Creighton, Rachel Schiff, Xiaoyong Fu et al.|Breast Cancer Research|2010Cited by 258
A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast CancersBryan T. Hennessy, Gordon B. Mills|Clinical Proteomics|2010Cited by 247
Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM StudyLudwig Kappos, Till Sprenger, Robert J. Fox et al.|JAMA Neurology|2021Cited by 218